Covered recipient · General Payments record
MEGAN N PELC
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2023–2024
$933.07
- Reported across 28 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $673.50 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $220.88 | 6 |
| Abbott Laboratories | $153.89 | 1 |
| Acerta Pharma LLC | $97.50 | 2 |
| PFIZER INC. | $92.00 | 4 |
| Amgen Inc. | $55.14 | 3 |
| Supernus Pharmaceuticals, Inc. | $32.26 | 2 |
| Mylan Specialty L.P. | $21.83 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $153.89 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124991184 | CMS |
| Amgen Inc. | $21.67 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117652648 | CMS |
| Amgen Inc. | $13.97 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117652650 | CMS |
| Amgen Inc. | $19.50 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117652652 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.25 | 04/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104633815 | CMS |
| AstraZeneca Pharmaceuticals LP | $77.25 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104410773 | CMS |
| Mylan Specialty L.P. | $21.83 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147329638 | CMS |
| Novo Nordisk Inc | $103.91 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100380983 | CMS |
| Novo Nordisk Inc | $7.08 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100270939 | CMS |
| Novo Nordisk Inc | $8.08 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100499783 | CMS |
| Novo Nordisk Inc | $82.30 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100466394 | CMS |
| Novo Nordisk Inc | $8.36 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100297591 | CMS |
| Novo Nordisk Inc | $11.15 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100233494 | CMS |
| PFIZER INC. | $22.31 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131120881 | CMS |
| PFIZER INC. | $15.26 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132002593 | CMS |
| PFIZER INC. | $28.77 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131457791 | CMS |
| PFIZER INC. | $25.66 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131843708 | CMS |
| Supernus Pharmaceuticals, Inc. | $13.31 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147856225 | CMS |
| Supernus Pharmaceuticals, Inc. | $18.95 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147856227 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.